Ipopema: recommendation "buy" with the target price of PLN 400
06-07-2017

Analysts of Ipopema Securities in a report dated July 6th, 2017 upgraded their recommendation for AmRest to "buy" from "sell" and raised the target price to PLN 400 per share from PLN 200.